Table 5.
Predictors of potential drug- drug interactions
| Variable (reference) | OR | 95% CI | P |
|---|---|---|---|
| Age (<35 years) | |||
| >35 years | 0.721 | 0.378- 1.375 | 0.322 |
| Gender (female) | |||
| Male | 1.064 | 0.563- 2.009 | 0.850 |
| Nationality (expatriates) | |||
| UAE Nationals | 1.302 | 0.690- 2.457 | 0.418 |
| Length of stay (<15 days) | |||
| ≥15 days | 0.440 | 0.216- 0.893 | 0.021* |
| Presence of comorbidities (no comorbidity) | |||
| Yes | 1.180 | 0.592- 2.354 | 0.640 |
| Number of drugs (≤2 drugs) | |||
| >2 drugs | 3.266 | 2.098- 5.084 | 0.000** |
| Polypharmacy (no polypharmacy) | |||
| Minor polypharmacy | 0.0100 | 0.0006- 0.1706 | 0.0015* |
| Moderate polypharmacy | 0.0067 | 0.0004- 0.1233 | 0.0008** |
| Major polypharmacy | 0.0049 | 0.0001- 0.3045 | 0.0116* |
*P<0.05: Statistically significant, **P<0.001: Statistically highly significant. OR: Odds ratio, CI: Confidence interval